Target intelligence / Profile preview

Rotavirus VP4 and VP7 capsid proteins (VP4/VP7)

Target
VP4/VP7
Molecular classification
Viral capsid protein, Glycoprotein, Spike protein, Antigen
01

Overview

Rotavirus VP4 and VP7 are the two primary proteins forming the outer capsid of the rotavirus virion, which is the leading cause of severe dehydrating diarrhea in infants and young children globally [1]. VP4 is a protease-sensitive spike protein that mediates viral attachment to host cell receptors, such as sialic acids or histo-blood group antigens, and facilitates membrane penetration [2]. VP7 is a calcium-binding glycoprotein that forms the outer shell's surface and plays a critical role in the structural integrity of the virion and the entry process [4]. These two proteins are the major targets of the host's neutralizing antibody response and define the virus's dual classification system: G-types (VP7) and P-types (VP4) [2]. Current preventative strategies rely heavily on live-attenuated vaccines, such as Rotarix and RotaTeq, which present these antigens to the immune system to elicit protective IgA and IgG responses [3]. Beyond vaccines, these proteins are targets for the development of passive immunization strategies using monoclonal antibodies or nanobodies to block viral infection [4]. [1] StatPearls: Rotavirus (https://www.ncbi.nlm.nih.gov/books/NBK558954/); [2] Settembre, E. C., et al. (2011). Atomic model of an infectious rotavirus particle. EMBO Journal, 30(2), 408–416; [3] Burny, W., et al. (2014). Rotavirus-specific cytotoxic T cell responses. Vaccine, 32(27), 3341-3343; [4] Crawford, S. E., et al. (2017). Rotavirus infection. Nature Reviews Disease Primers, 3, 17083.

Other names
Outer capsid proteinsVP4 spike proteinVP7 glycoproteinG-antigenP-antigenVP4/VP7 complex
02

Mechanism of action

Induction of neutralizing antibodies (IgA and IgG) that target the VP4 and VP7 proteins to block viral attachment and entry into intestinal epithelial cells.

03

Biological functions

Viral attachmentCell entryMembrane penetrationHost cell recognitionCapsid assembly
04

Disease associations

Rotavirus infectionGastroenteritisSevere dehydration
05

Safety considerations

IntussusceptionVaccine-derived reassortmentViral shedding
06

Interacting drugs

Rotarix

4 more in the full profile.

07

Biomarkers

Serum anti-rotavirus IgA titersVP4/VP7-specific neutralizing antibody titersStool rotavirus antigen

Beyond the preview

Go deeper on Rotavirus VP4 and VP7 capsid proteins (VP4/VP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rotavirus VP4 and VP7 capsid proteins (VP4/VP7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call